GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aptamer Group APTA.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.28p

-3.51%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Aptamer Group — daily APTA

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Aptamer Group on TradingView ↗
Market value
£7.4m
Last close × shares
Volume
2.2m
Shares, 9 Nov 2026

About Aptamer Group

Its shares trade on LSE under the ticker APTA.L. It has been listed since 22 December 2021. In the fiscal year to 30 June 2026, it reported revenue of £1.5m and a net loss of £1.9m. At that date it held total assets of £7.2m and shareholders' equity of £5.7m.

Aptamer Group Plc is a biotechnology company, which engages in the development of Optimer binders for use in research, diagnostics, and therapeutics. The company is headquartered in York, North Yorkshire. The company went IPO on 2021-12-22. The company offers custom Optimer selection and development services. The company delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. The company develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.

Figures and description from our data supplier, not checked against the company's own report.

More about Aptamer Group →

Latest on Aptamer Group

Our reporting

We have not reported on Aptamer Group yet.

Next results

1 Apr 2027

Due on 1 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Aptamer Group's ticker?

Aptamer Group trades as APTA.L on LSE, under ISIN GB00BNRRP542.

What was Aptamer Group's last closing price?

0.28p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Aptamer Group next report results?

Results are expected on 1 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.